Natural Science Foundation of Hunan Province [2022JJ30523]; Project of Hunan Provincial Health Commission [202203072849]; University of South China Clinical Research 4310 Program [2023SK4050]; Clinical Medical Research Center of Hunan Province; [20224310NHYCG08]
机构署名：
本校为第一且通讯机构
院系归属：
医学院
摘要：
OBJECTIVES: Intravenous thrombolysis therapy (IVT) with recombinant tissue plasminogen activator has proven to be a beneficial treatment for acute ischemic stroke (AIS) patients when administered within 4.5h after a stroke. This study aimed to investigate an available and inexpensive predictive tool for early neurological deterioration in AIS. METHODS: Patients admitted to our department with acute stroke who were given IVT with recombinant tissue plasminogen activator within 4.5h of stroke onset were included in the study. The NIH stroke scale...
